5-dimethylamino-naphthalene-1-sulfonic acid allylamide | 25458-73-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 5-dimethylamino-naphthalene-1-sulfonic acid allylamide
• 英文别名: N-allyl-5-(dimethylamino)naphthalene-1-sulfonamide；1-Naphthalenesulfonamide, 5-(dimethylamino)-N-2-propenyl-；5-(dimethylamino)-N-prop-2-enylnaphthalene-1-sulfonamide
• CAS: 25458-73-5
• 化学式: C₁₅H₁₈N₂O₂S
• 分子量: 290.386
• InChiKey: VLFHFUWLHKRJHQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  57.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  Cys-Glu-Asp-Leu-Phe-Tyr-Gln-NH₂ 、 5-dimethylamino-naphthalene-1-sulfonic acid allylamide 在 2-[[三(羟甲基)甲基]氨基]乙磺酸 、 2-甲氧基苯乙酮 、 安息香双甲醚 作用下， 以 水 为溶剂， 反应 3.0h， 生成 S-dansyl-Cys-Glu-Asp-Leu-Phe-Tyr-Gln-NH₂
  参考文献：
  名称：

  在低共熔溶剂中自由基介导的硫醇-烯“点击”反应用于生物共轭

  摘要：

  在此，我们报告了深共晶溶剂 (DES) 在自由基介导的氢硫醇化反应中的首次应用。在紫外线和大气氧气介导的条件下，硫醇-烯反应应用于 DES 中的氨基酸和肽连接。这些条件有助于使用“绿色”方法高效合成生物分子靶标，并完全回收反应介质。能够结合 SARS-CoV-2 刺突蛋白的血管紧张素转换酶 2 的最小序列模拟物的荧光标记和糖基化已被证明可用于抑制 COVID-19 感染性的研究。

  DOI：

  10.1039/d1gc03714e
• 作为产物：
  描述：

  (2,4,6-Trichlorophenyl) 5-(dimethylamino)naphthalene-1-sulfonate 、 丙烯胺 在 三乙胺 作用下， 以 N-甲基吡咯烷酮 为溶剂， 反应 0.17h， 以77%的产率得到5-dimethylamino-naphthalene-1-sulfonic acid allylamide
  参考文献：
  名称：

  Trichlorophenol (TCP) sulfonate esters: A selective alternative to pentafluorophenol (PFP) esters and sulfonyl chlorides for the preparation of sulfonamides

  摘要：

  在常规加热和微波辐照条件下，2,4,6-三氯苯酚 (TCP) 磺酸酯会发生有效的氨基溶解；这些物质的反应活性使得全氟辛基磺酸酯的化学选择性转化得以实现。

  DOI：

  10.1039/b614604j

文献信息

• Direct Synthesis of Sulfonamides and Activated Sulfonate Esters from Sulfonic Acids
  作者：Stephen Caddick、Jonathan D. Wilden、Duncan B. Judd

  DOI：10.1021/ja0397658

  日期：2004.2.1

  the direct coupling of sulfonic acid salts with amines and alcohols using the reagent triphenylphosphine ditriflate is described. A new reusable polymer-supported reagent for these transformations under heterogeneous conditions is also described. These methods provide a fundamentally new approach to making small molecules containing the sulfonamide functional group.

  描述了通过使用三苯基膦二三氟甲磺酸酯试剂直接偶联磺酸盐与胺和醇来制备磺酰胺和活化磺酸酯的通用新方法。还描述了一种新的可重复使用的聚合物支持的试剂，用于在异质条件下进行这些转化。这些方法为制备含有磺酰胺官能团的小分子提供了一种全新的方法。
• [EN] ANTIBACTERIAL AGENT<br/>[FR] AGENT ANTIBACTÉRIEN
  申请人：UNIV OXFORD INNOVATION LTD

  公开号：WO2016185200A1

  公开（公告）日：2016-11-24

  The invention provides a compound which is a peptide derivative of formula (1) as defined in the claims or a salt thereof: RG is H, -CH2-RGA or C1-12 hydrocarbyl optionally substituted with 1 to 4 substituents selected from -OR', -NO2, -CN, halogen and 5-6 membered heterocyclyl; or RG and RN1 together form a 5-6 membered heterocyclic ring which is optionally substituted with 1 to 3 substituents selected from Ra, -OR' and halogen; RGA is C1-11 hydrocarbyl optionally substituted with 1 to 4 substituents selected from -NR'R", -OR', -NO2, -CN, halogen and 5-6 membered heterocyclyl; RSis C1-16 hydrocarbyl, a 5-10 membered heterocyclyl or heteroaryl group, -(C1-4 alkylene)-RSA or -(C1-4 alkylene)-L-RSA; RSA is C1-16 hydrocarbyl, or a 5-10 membered heterocyclyl or heteroaryl group; L is -SO2-; and wherein RS and RSA are optionally substituted with a group Rb and/or from 1 to 5 substituents selected from Ra, -NR'R", -OR', -NO2, -CN, -C(O)R', -C(O)OR', -C(O)NR'R", -0-C(0)R', -N(R')-C(0)R", -SR', -S(O)R', -S(O)2R', -S(O)2OR', -P(O)(OR')(OR"), =O, -SiR'R"R" and halogen; or Rs and an RC1 together form a 5-6 membered heterocyclyl ring which is optionally substituted with 1 to 3 substituents selected from Ra, -OR' and halogen; Rb is phenyl, benzyl, C3-6 cycloalkyl or 5-6 membered heterocyclyl; Q is -C(O)-N(RN2)-, -C(O)-C(R'R")-, -C(O)-O- -N(RN2)-C(O)-, -C(R'R")- C(O)-, -O-C(O)-, -C(R'R")-C(R"'R"")-, -C(R'R")-O- -O-C(R'R")-, -C(R'R")-N(RN2)-, -N(RN2)-C(R'R")- or -C(R')=C(R")-; Z is a group selected from -C(O)-O-RO and -CN4R' (tetrazolyl); RO is H or C1-12 hydrocarbyl optionally substituted with 1 to 4 substituents selected from -NR'R", -OR', -NO2, -CN, -C(O)R', -C(O)OR', -C(O)NR'R", -O-C(O)R', -N(R')- C(O)R", -SR', -S(O)R', -S(O)2R', -S(O)2OR', -P(O)(OR')(OR"), =O, halogen and 5-6 membered heterocyclyl; or RO and an RC2 together form a 5-6 membered heterocyclyl ring which is optionally substituted with 1 to 3 substituents selected from Ra, -OR' and halogen; each RN1 and RN2 is independently H or C1-4 alkyl; each RC1, RC2, R', R", R" and R"" is independently H or C1-4 alkyl and is optionally substituted with 1 to 3 substituents selected from halogen, -OH and -O-C1-4 alkyl; and each Ra is independently C1-4 alkyl which is optionally substituted with 1 to 3 halogen atoms.

  该发明提供了一种化合物，其为以下公式（1）中所定义的肽衍生物或其盐：RG为H，-CH2-RGA或C1-12烃基，可选地取代为1至4个从-OR'，-NO2，-CN，卤素和5-6成员杂环基中选择的取代基；或RG和RN1一起形成一个5-6成员杂环环，可选地取代为1至3个从Ra，-OR'和卤素中选择的取代基；RGA为C1-11烃基，可选地取代为1至4个从-NR'R"，-OR'，-NO2，-CN，卤素和5-6成员杂环基中选择的取代基；RS为C1-16烃基，一个5-10成员杂环基或杂芳基，-(C1-4烷基)-RSA或-(C1-4烷基)-L-RSA；RSA为C1-16烃基，或一个5-10成员杂环基或杂芳基；L为-SO2-；其中RS和RSA可选地取代为一个基团Rb和/或从Ra，-NR'R"，-OR'，-NO2，-CN，-C(O)R'，-C(O)OR'，-C(O)NR'R"，-O-C(0)R'，-N(R')-C(0)R"，-SR'，-S(O)R'，-S(O)2R'，-S(O)2OR'，-P(O)(OR')(OR")，=O，-SiR'R"R"和卤素中选择的1至5个取代基；或Rs和RC1一起形成一个5-6成员杂环环，可选地取代为1至3个从Ra，-OR'和卤素中选择的取代基；Rb为苯基，苄基，C3-6环烷基或5-6成员杂环基；Q为-C(O)-N(RN2)-，-C(O)-C(R'R")-，-C(O)-O- -N(RN2)-C(O)-，-C(R'R")- C(O)-，-O-C(O)-，-C(R'R")-C(R"'R"")-，-C(R'R")-O- -O-C(R'R")-，-C(R'R")-N(RN2)-，-N(RN2)-C(R'R")-或-C(R')=C(R")-；Z为从-C(O)-O-RO和-CN4R'（四唑基）中选择的基团；RO为H或C1-12烃基，可选地取代为1至4个从-NR'R"，-OR'，-NO2，-CN，-C(O)R'，-C(O)OR'，-C(O)NR'R"，-O-C(O)R'，-N(R')-C(O)R"，-SR'，-S(O)R'，-S(O)2R'，-S(O)2OR'，-P(O)(OR')(OR")，=O，卤素和5-6成员杂环基中选择的取代基；或RO和RC2一起形成一个5-6成员杂环环，可选地取代为1至3个从Ra，-OR'和卤素中选择的取代基；每个RN1和RN2独立地为H或C1-4烷基；每个RC1，RC2，R'，R"，R"和R""独立地为H或C1-4烷基，并可选地取代为1至3个从卤素，-OH和-O-C1-4烷基中选择的取代基；每个Ra独立地为可选地取代为1至3个卤素原子的C1-4烷基。
• Fluorescent Nanoparticles
  申请人：Wang Xiaorong

  公开号：US20100016512A1

  公开（公告）日：2010-01-21

  A fluorescent nanoparticle includes a core comprising an alkenylbenzene; an intermediate layer, an outer shell layer, and a fluorescent portion. The fluorescent portion includes a structure represented by the following formula: wherein L is a direct bond or a linker group, and F is any fluorescent moiety. The fluorescent portion is located in at least one of the following locations: the core, the intermediate layer, or the shell layer of the nanoparticle. Methods for making the fluorescent nanoparticle are also described.

  一种荧光纳米粒子包括一个核心，其中包括一个烯基苯；一个中间层，一个外壳层和一个荧光部分。荧光部分包括以下公式所表示的结构：其中L是直接键或连接基团，F是任何荧光基团。荧光部分位于纳米粒子的核心、中间层或外壳层中的至少一个位置。还描述了制备荧光纳米粒子的方法。
• N-2-Propenyl-(5-dimethylamino)-1-naphthalene Sulfonamide, a Novel Fluorescent Monomer for the Molecularly Imprinted Polymer-Based Detection of 2,4-Dinitrotoluene in the Gas Phase
  作者：Nicholas W. Turner、Clovia I. Holdsworth、Adam McCluskey、Michael C. Bowyer

  DOI：10.1071/ch12155

  日期：——

  Fluorescent molecularly imprinted polymers (MIP) specific for 2,4-dinitrotoluene (DNT) have been synthesised using a novel monomer N-2-propenyl-(5-dimethylamino)-1-naphthalene sulfonamide. Three formats of the polymer were produced: a traditional bulk monolith ground into particles, a flexible, but highly cross-linked plasticiser-modified free standing membrane, and a hybrid material consisting of particles embedded in a poly(acrylonitrile) phase inversed film. Within all materials, a clearly defined imprinting effect was observed upon exposure to DNT vapour at room temperature. In all cases, preferential rebinding of DNT to the molecularly imprinted materials (3–5 times) over their non-imprinted (NIP) equivalents was evident within <10 min of contact with the DNT vapour stream. Fluorographic images of the fluorescent polymers showed the DNT binding-induced quenching to be significantly higher in the MIP material than in the non-imprinted control polymer.

  利用新型单体 N-2-丙烯基-(5-二甲基氨基)-1-萘磺酰胺合成了 2,4-二硝基甲苯（DNT）特异性荧光分子印迹聚合物（MIP）。生产出了三种形式的聚合物：一种是磨成颗粒的传统块状单体，一种是柔韧但高度交联的增塑剂改性独立膜，还有一种是由嵌入聚丙烯腈相倒膜的颗粒组成的混合材料。在所有材料中，室温下接触 DNT 蒸汽时都能观察到明显的压印效果。在所有情况下，在与 DNT 蒸汽流接触 10 分钟内，DNT 与分子印迹材料的优先再结合（3-5 倍）明显优于未印迹（NIP）材料。荧光聚合物的荧光图像显示，分子印迹材料的 DNT 结合淬灭效果明显高于未印迹的对照聚合物。
• US4326008A
  申请人：——

  公开号：US4326008A

  公开（公告）日：1982-04-20